Safety of Concomitant Therapy with Eptifibatide and Enoxaparin in Patients Undergoing Percutaneous Coronary Intervention: Results of the Coronary Revascularization using Integrilin and Single Bolus Enoxaparin Study. - Safety of Concomitant Therapy with Eptifibatide and Enoxaparin in Patients Undergoing Percutaneous Coronary Intervention: Results of the Coronary Revascularization using Integrilin and Single Bolus Enoxaparin Study.

Description:

The goal of this study was to assess whether use of enoxaparin during percutaneous coronary intervention (PCI) increased bleeding compared with unfractionated heparin, when used on top of background therapy with eptifibatide.